Today: 9 June 2026
IREN Limited stock: what Monday looks like after a $50 swing and bitcoin back near $90,000
12 January 2026
2 mins read

IREN Limited stock: what Monday looks like after a $50 swing and bitcoin back near $90,000

New York, Jan 11, 2026, 18:13 EST — Market closed

  • IREN closed Friday 0.7% higher at $46.03, following a volatile session.
  • Bitcoin stayed close to $90,000, keeping crypto-related stocks in the spotlight on Monday.
  • Traders are focused on how AI buildouts are progressing and eyeing the upcoming earnings window for fresh details on funding and timelines.

IREN Limited shares ended Friday up 0.7% at $46.03, swinging between a high near $50 and a low of $45.52 amid heavy volume in a choppy session. With U.S. markets closed Sunday, the stock is poised for a new test when trading picks up again Monday.

The move is significant since IREN is caught up in two high-velocity trades simultaneously: bitcoin-linked miners and the expansion of power-hungry data centers for artificial intelligence. When either trend pivots, the stock reacts sharply—and not always predictably.

That’s the scene as the week kicks off. Investors are wrestling with valuing a business still tied to bitcoin, while it pours cash into boosting AI capabilities. Cash flow and timing are now front and center in every discussion.

Bitcoin hovered near $90,371, holding steady on the day. Stocks tied to crypto and data centers showed mixed moves Friday: Applied Digital surged roughly 18%, Hut 8 climbed about 3.6%, Riot Platforms ticked up 1.3%, and Marathon Digital edged down 2.0%.

IREN is banking on a long-term AI cloud deal with Microsoft, pegged at around $9.7 billion and featuring a 20% upfront payment. According to the company, the agreement involves rolling out NVIDIA GB300 GPUs—key chips for AI model training and operation—at its Childress, Texas site in stages through 2026. The project includes building new liquid-cooled data centers designed to handle 200 megawatts of “IT load,” which represents the actual power servers consume. IREN

Co-CEO Daniel Roberts described the deal as a “milestone partnership with Microsoft.” Jonathan Tinter, a Microsoft executive, said the collaboration is “delivering cutting-edge AI infrastructure for our customers.” GlobeNewswire

Execution remains the toughest challenge. Reuters reported that the Microsoft deal includes strict delivery timelines, with the agreement subject to termination if IREN misses them. This underscores that the deal hinges not only on AI chip demand but also on delivering at scale and on schedule.

That raises another key question investors are focused on: funding. IREN says it plans to cover capital spending linked to the contract using existing cash, customer prepayments, operating cash flow, and some additional financing moves.

Nasdaq’s earnings calendar currently points to IREN reporting around Feb. 11, but the company hasn’t locked in a date yet. Investors will be focused on any news about deployment schedules, spending forecasts, and shifts in revenue growth as new capacity kicks in.

But the downside case is straightforward: bitcoin dips, risk appetite wanes, and the stock’s “AI data center” premium comes under pressure if financing costs climb or construction delays hit. Another volatile swing like Friday’s—surging toward $50 before retreating—would catch few shorts or momentum traders off guard.

Monday’s session boils down to one key focus: how bitcoin behaves near the $90,000 mark and if the wider crypto and AI-infrastructure stocks hold their ground. Keep an eye on mid-February earnings, too—when IREN must deliver updated figures and timelines to back its narrative.

Stock Market Today

  • Wheat Futures Rise as Export Inspections Show Mixed Data
    June 9, 2026, 9:19 AM EDT. Wheat futures gained on Monday, with Chicago SRW up 5-7 cents, KC HRW up 9-11 cents, and MPLS spring wheat rising slightly. Export inspections reported 319,730 MT shipped in the week ending June 4, down 20.65% from the previous week and 1.38% below last year. Mexico led exports with 83,211 MT. Managed money increased net shorts in Chicago wheat futures to 57,871 contracts, hitting a record bear move since 2006. Ukraine's wheat crop estimate rose 1.8 MMT to 21.7 MMT. July 26 CBOT Wheat futures closed at $5.86 ½, up 6 ½ cents, reflecting bullish momentum amid volatile trading conditions.

Latest articles

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
AmpliTech’s 5G Radio Test Moves AMPG Shares

AmpliTech’s 5G Radio Test Moves AMPG Shares

9 June 2026
AMPG soared 26.7% to $6.57 after AmpliTech revealed its 64T64R Massive MIMO radio was the only one of its kind at O-RAN PlugFest, showing interoperability with major carriers’ equipment, but no new orders were announced, leaving sales conversion as the key investor focus.
Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

9 June 2026
Factorial Energy surged 16% to $13.80 in its Nasdaq debut as FAC, with premarket trading near $20.70, after replacing CGCT via SPAC merger that raised over $100 million for battery commercialization and implied a $1.3 billion equity value; former CGCT shares now trade as FAC, with founders retaining majority voting power and staged lock-up releases ahead.
Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

9 June 2026
Pfizer shares fell 1.7% premarket to $25.62 as investors weighed an FDA label expansion for hemophilia drug Hympavzi—now the first subcutaneous non-factor therapy for children 6-11 with hemophilia B—against slower progress in obesity drugs, with mid-stage data for weight-loss shot berobenatide showing a 23.3% vomiting rate and no immediate growth catalyst for the $147 billion company.
Snap Shares Fall Even as Nasdaq Gains; June 16 in Focus

Snap Shares Fall Even as Nasdaq Gains; June 16 in Focus

9 June 2026
Snap Inc. shares fell 1.9% to $5.65, underperforming a rising Nasdaq and leaving the stock 46% below its 52-week high, as investors weigh weak ad revenue growth, North American user declines, and cost-cutting moves against ongoing competitive pressure from Meta and TikTok.
Uber stock heads into Monday with robotaxi rules back in focus after Waymo protest
Previous Story

Uber stock heads into Monday with robotaxi rules back in focus after Waymo protest

Frontline (FRO) stock: $2 billion VLCC swap puts tanker owner back in focus before Monday’s open
Next Story

Frontline (FRO) stock: $2 billion VLCC swap puts tanker owner back in focus before Monday’s open

Go toTop